Exchange: NASDAQ·Updated 07:45 PM EST

FBLG News

News
all
press releases
FibroBiologics, Inc. (FBLG) Discusses Fibroblast Based Cell Therapy Strategy and Clinical Progress Transcript
FibroBiologics, Inc. (FBLG) Discusses Fibroblast Based Cell Therapy Strategy and Clinical Progress Transcript...
SeekingAlpha
FibroBiologics, Inc. (FBLG) Discusses Fibroblast Based Cell Therapy Strategy and Clinical Progress Transcript
FibroBiologics, Inc. (FBLG) Discusses Fibroblast Based Cell Therapy Strategy and Clinical Progress Transcript...
SeekingAlpha
More News
FibroBiologics Reports Third Quarter 2026 Financial Results; Highlights Upcoming Catalysts FibroBiologics Reports Third Quarter 2026 Financial Results; Highlights Upcoming CatalystsPR NewswireHOUSTON, Nov. 16, 2026 Initial safety data from Phase 1/2 CYWC628 diabetic foot ulcer trial expected in Q4...
PR Newswire
FibroBiologics Announces Update On Its Intellectual Property Portfolio FibroBiologics Announces Update On Its Intellectual Property PortfolioPR NewswireHOUSTON, Nov. 12, 2026 Portfolio Extends Its Lead in Fibroblast Intellectual Property With 170 Issued Patents and 325+ Patents Issued and...
PR Newswire
FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory Agents FibroBiologics Announces Grant of European Patent for Fibroblast Delivery of Tumor Inhibitory AgentsPR NewswireHOUSTON, Nov. 5, 2026 Newly Granted Patent Covers Methods of Preparing Fibroblasts to...
PR Newswire
FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc Disease at the North American Spine Society 2026 Annual Meeting FibroBiologics Presents Preclinical Data on Fibroblast Spheroid-Derived Chondrocyte Spheroids for Degenerative Disc...
PR Newswire
FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs FibroBiologics Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated...
PR Newswire
FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the BodyPR NewswireHOUSTON, Oct. 7, 2026New approach...
PR Newswire
FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic Activity FibroBiologics Announces Grant of European Patent for Methods of Enhancing Fibroblast Therapeutic ActivityPR NewswireHOUSTON, Sept. 29, 2026 Newly Granted Patent Covers Methods of Augmenting...
PR Newswire
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific OfficerPR NewswireHOUSTON, Sept. 17, 2026 HOUSTON, Sept. 17, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq...
PR Newswire
FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing PR Newswire HOUSTON, Sept. 3, 2026 Newly Issued Patent Covers Topical...
PR Newswire

Advertisement|Remove ads.